Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $580.9100 (0.61%) ($564.3800 - $584.0000) on Fri. Sep. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.2% (three month average) | RSI | 40 | Latest Price | $580.9100(0.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -1.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) XLV(45%) SPLV(40%) IVW(38%) SPY(38%) | Factors Impacting REGN price | REGN will decline at least -1.1% in a week (0% probabilities). VIXM(-20%) VXX(-7%) UUP(-7%) TBT(-6%) DRIV(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.1% (StdDev 2.2%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $607.09 | 5 Day Moving Average | $596.19(-2.56%) | 10 Day Moving Average | $601.08(-3.36%) | 20 Day Moving Average | $607.09(-4.31%) | To recent high | -11.7% | To recent low | 0.6% | Market Cap | $61.593b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |